Recent News

• 03.26.2026 - Beyond Air, Inc. Announces Resignation of Steve Lisi, CEO, and Appointment of Robert Goodman, Chief Commercial Officer, as CEO
• 03.17.2026 - Beyond Cancer Reports Early Clinical Activity and Favorable Safety Profile with Interim Data from Phase 1 UNO Trial
• 02.13.2026 - Beyond Air® Reports Fiscal Third Quarter 2026 Financial Results and Provides Corporate Update
• 01.27.2026 - Beyond Air to Participate in Two Upcoming Healthcare Investor Conferences
• 01.26.2026 - Beyond Air Schedules Third Fiscal Quarter 2026 Financial Results Conference Call and Webcast

Recent Filings

• 02.17.2026 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors
• 02.17.2026 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors
• 02.13.2026 - 8-K Current report
• 02.13.2026 - 10-Q Quarterly report [Sections 13 or 15(d)]
• 02.13.2026 - EX-99.1 EX-99.1
• 02.10.2026 - 424B3 Prospectus [Rule 424(b)(3)]
• 02.09.2026 - EFFECT Notice of Effectiveness
• 02.02.2026 - 8-K Current report
• 01.30.2026 - S-3 Registration statement under Securities Act of 1933
• 01.20.2026 - 8-K Current report